Profile
APUS ZTS HLN TAK TEVA ITCI
Company Name Apimeds Pharmaceuticals US, Inc Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $0.13K $70.23B $48.53B $47.75B $19.40B $14.05B
Employees 0.00K 13.80K 24.56K 49.28K 33.89K 0.86K
CEO Mr. Erik C. Emerson Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
APUS ZTS HLN TAK TEVA ITCI
Quant Rating Score 3 3 3 1 1
Quant Rating Neutral Neutral Neutral Strong Sell Strong Sell
Trading
APUS ZTS HLN TAK TEVA ITCI
Last Close $0.00001 $159.27 $10.74 $14.36 $16.93 $131.87
High 52 - $196.48 $10.77 $15.37 $22.77 $131.91
Low 52 - $144.45 $8.24 $12.6 $12.82 $64.96
Price vs. 52 Week High 0 % -18.94 % -0.28 % -6.57 % -25.65 % -0.03 %
Price vs. 52 Week Low 0 % 10.26 % 30.34 % 13.97 % 32.06 % 103 %
Total Return
APUS ZTS HLN TAK TEVA ITCI
1 Month Return 0 % 8.35 % 11.53 % 3.53 % 32.06 % 0 %
3 Month Return 0 % -7.35 % 10.95 % 6.92 % 0.71 % 3.74 %
6 Month Return 0 % -9.93 % 11.76 % 4.21 % -1.05 % 44.45 %
9 Month Return 0 % -14.02 % 9.48 % 3.53 % -2.87 % 79.15 %
YTD Return 0 % -2.25 % 12.58 % 8.46 % -23.19 % 57.89 %
1 Year Return 0 % -5.78 % 30.34 % 8.38 % 4.18 % 103 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
APUS ZTS HLN TAK TEVA ITCI
Dividend Yield Percentage (TTM) - 1.18 % 0.02 % 4.58 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 2.05 % - 1.76 % 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 0.07 % 196 % - -
Payout Ratio (TTM) - 31.62 % - 145.09 % - -
Profitability
APUS ZTS HLN TAK TEVA ITCI
Gross Profit Margin TTM 69.85 % 61.52 % 54.74 % 48.74 % 91.63 %
Return on Assets TTM 17.46 % 4.2 % 1.38 % -4.17 % -5.46 %
Return on Equity TTM 49.65 % 8.73 % 2.83 % -26.15 % -7.4 %
Return on Capital Employed TTM 31.33 % 7.74 % 3.62 % -1.14 % -10.05 %
Net Income Per EBT TTM 79.35 % 75.5 % 89.75 % 127.75 % 100.64 %
EBT Per Ebit TTM 92.36 % 86.58 % 49.18 % 423.43 % 63.57 %
EBIT Per Revenue TTM 36.65 % 19.64 % 10.3 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM 43.79 % - 22.2 % 6.9 % -430.93 %
Receivables Turnover TTM 7.03 5.9 6.23 5.41 4.09
Payables Turnover TTM 6.45 2.19 4.5 3.85 2.18
Inventory Turnover TTM 1.21 3.63 1.66 2.82 2.17
Fixed Asset Turnover TTM 256.4 % 584.75 % 226.93 % 334.34 % 4569.25 %
Asset Turnover TTM 65.01 % 32.73 % 30.31 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM 6.55 - 677.91 1.1 -0.71
Free Cash Flow Per Share TTM 5.1 - 483.45 0.66 -0.71
Cash Per Share TTM 440.62 % 24.05 % 33229.49 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM 31.9 % - 23.47 % 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 77.82 % - 71.32 % 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM 43.79 % - 22.2 % 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM 30.56 - 8.85 28.03 -191.12
Price To Operating Cash Flows Ratio TTM 24.02 - 6.31 16.65 -185.85
Price Cash Flow Ratio TTM 24.02 - 6.31 16.65 -185.85
Income Statement (TTM)
APUS ZTS HLN TAK TEVA ITCI
Revenue $9.26B $11.23B $4263.76B $16.54B $0.68B
Gross Profit $6.54B $6.95B $2832.26B $8.06B $0.62B
Gross Profit Ratio 70.62% 61.85% 66.43% 48.74% 91.63%
EBITDA $3.87B $2.51B $874.6B $0.72B $-0.12B
Net Income $2.49B $1.44B $144.07B $-1.64B $-0.07B
EPS Diluted 5.47 0.32 45.58 -1.45 -0.72
Balance Sheet (MRQ)
APUS ZTS HLN TAK TEVA ITCI
Long Term Debt $5.39B $8.54B $5029.93B $16B $0.01B
Total Liabilities $9.47B $18.09B $7834.79B $33.61B $0.22B
Total Equity $4.77B $16.22B $7274.01B $5.73B $1.15B
Total Investments $0B $0.08B $445.7B $0B $0.69B
Total Debt $6.74B $10.1B $4843.75B $18.08B $0.02B
Total Assets $14.24B $34.32B $15108.79B $39.33B $1.37B
Cash Flow Statement (TTM)
APUS ZTS HLN TAK TEVA ITCI
Net Income $2.5B $1.44B $144.07B $-1.96B $-0.07B
Inventory $-0.04B $0.22B $-115.74B $0.17B $-0.01B
Dividends Paid $-0.79B $-0.57B $-287.19B $0B $0B
Operating Cash Flow $2.95B $2.3B $716.34B $1.25B $-0.07B
Capital Expenditure $-0.66B $-0.25B $-480.73B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.85
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.16
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.68
ALVOW Alvotech 1.79
AMPH Amphastar Pharmaceuticals, Inc. 24.11
AMRX Amneal Pharmaceuticals, Inc. 7.41
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.3
AQST Aquestive Therapeutics, Inc. 2.79
ASRT Assertio Holdings, Inc. 0.61
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.39
AYTU Aytu BioPharma, Inc. 1.25
Unlock